| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.6 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.6 |